Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZWS
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 5.48 3.14 2.98
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -15.40 5.29 6.25
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value 2.02 9.30 9.12
Cash 69.01 1.00 0.59
Capex 18.18 -0.03 -0.03
Free Cash Flow 22.09 0.57 0.47
Revenue -0.63 2.30 2.31
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -0.90 0.43 0.43
Operating Margin 10.99 0.15 0.14
ROA 19.19 0.01 0.01
ROE 17.95 0.03 0.02
ROIC 13.85 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZWS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZWS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZWS is permitted for members.